180 related articles for article (PubMed ID: 14691611)
21. Replacing 99mTc with 111In improves MORF/cMORF pretargeting by reducing intestinal accumulation.
Liu G; Cheng D; Dou S; Chen X; Liang M; Pretorius PH; Rusckowski M; Hnatowich DJ
Mol Imaging Biol; 2009; 11(5):303-7. PubMed ID: 19326173
[TBL] [Abstract][Full Text] [Related]
22. Radiolabeling of MAG3-morpholino oligomers with 188Re at high labeling efficiency and specific radioactivity for tumor pretargeting.
Liu G; Dou S; He J; Yin D; Gupta S; Zhang S; Wang Y; Rusckowski M; Hnatowich DJ
Appl Radiat Isot; 2006 Sep; 64(9):971-8. PubMed ID: 16730997
[TBL] [Abstract][Full Text] [Related]
23. An experimental and theoretical evaluation of the influence of pretargeting antibody on the tumor accumulation of effector.
Liu G; Dou S; Rusckowski M; Hnatowich DJ
Mol Cancer Ther; 2008 May; 7(5):1025-32. PubMed ID: 18483292
[TBL] [Abstract][Full Text] [Related]
24. Successful radiotherapy of tumor in pretargeted mice by 188Re-radiolabeled phosphorodiamidate morpholino oligomer, a synthetic DNA analogue.
Liu G; Dou S; Mardirossian G; He J; Zhang S; Liu X; Rusckowski M; Hnatowich DJ
Clin Cancer Res; 2006 Aug; 12(16):4958-64. PubMed ID: 16914585
[TBL] [Abstract][Full Text] [Related]
25. Cytosine residues influence kidney accumulations of 99mTc-labeled morpholino oligomers.
Liu G; He J; Zhang S; Liu C; Rusckowski M; Hnatowich DJ
Antisense Nucleic Acid Drug Dev; 2002 Dec; 12(6):393-8. PubMed ID: 12568313
[TBL] [Abstract][Full Text] [Related]
26. Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.
Maresca KP; Marquis JC; Hillier SM; Lu G; Femia FJ; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
Bioconjug Chem; 2010 Jun; 21(6):1032-42. PubMed ID: 20402463
[TBL] [Abstract][Full Text] [Related]
27. Preparation of (111)In-DTPA morpholino oligomer for low abdominal accumulation.
Liu G; Dou S; Rusckowski M; Greiner D; Hnatowich D
Appl Radiat Isot; 2010 Sep; 68(9):1709-14. PubMed ID: 20359901
[TBL] [Abstract][Full Text] [Related]
28. Human islet cell MORF/cMORF pretargeting in a xenogeneic murine transplant model.
Liu G; Dou S; Cheng D; Leif J; Rusckowski M; Streeter PR; Shultz LD; Hnatowich DJ; Greiner DL
Mol Pharm; 2011 Jun; 8(3):767-73. PubMed ID: 21361360
[TBL] [Abstract][Full Text] [Related]
29. Construction of a novel chimera consisting of a chelator-containing Tat peptide conjugated to a morpholino antisense oligomer for technetium-99m labeling and accelerating cellular kinetics.
Zhang YM; Tung CH; He J; Liu N; Yanachkov I; Liu G; Rusckowski M; Vanderheyden JL
Nucl Med Biol; 2006 Feb; 33(2):263-9. PubMed ID: 16546682
[TBL] [Abstract][Full Text] [Related]
30. Comparison between two labeled agents in mice using a coinjection-ratio approach in contrast to a conventional group approach.
Dou S; Wang Y; Barton B; Chen L; Rusckowski M; Shultz LD; Greiner DL; Liu G
Nucl Med Biol; 2014 Jan; 41(1):127-31. PubMed ID: 24210286
[TBL] [Abstract][Full Text] [Related]
31. Radiolabelling morpholinos with 188Re tricarbonyl provides improved in vitro and in vivo stability to re-oxidation.
He J; Liu C; Vanderheyden JL; Liu G; Dou S; Rusckowski M; Hnatowich DJ
Nucl Med Commun; 2004 Jul; 25(7):731-6. PubMed ID: 15208502
[TBL] [Abstract][Full Text] [Related]
32. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
Su FM; Beaumier P; Axworthy D; Atcher R; Fritzberg A
Nucl Med Biol; 2005 Oct; 32(7):741-7. PubMed ID: 16243650
[TBL] [Abstract][Full Text] [Related]
33. Intraperitoneal injection is not always a suitable alternative to intravenous injection for radiotherapy.
Dou S; Smith M; Wang Y; Rusckowski M; Liu G
Cancer Biother Radiopharm; 2013 May; 28(4):335-42. PubMed ID: 23469942
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice.
Vanderheyden JL; Liu G; He J; Patel B; Tait JF; Hnatowich DJ
Nucl Med Biol; 2006 Jan; 33(1):135-44. PubMed ID: 16459269
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo comparison of binding of 99m-Tc-labeled anti-CEA MAb F33-104 with 99m-Tc-labeled anti-CEA MAb BW431/26.
Watanabe N; Oriuchi N; Sugiyama S; Kuroki M; Matsuoka Y; Tanada S; Murata H; Inoue T; Sasaki Y
Nuklearmedizin; 1999; 38(4):115-9. PubMed ID: 10392376
[TBL] [Abstract][Full Text] [Related]
36. Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy.
Jung KH; Lee KH; Paik JY; Ko BH; Bae JS; Lee BC; Sung HJ; Kim DH; Choe YS; Chi DY
J Nucl Med; 2006 Dec; 47(12):2000-7. PubMed ID: 17138743
[TBL] [Abstract][Full Text] [Related]
37. Effects of antifolate drugs on the cellular uptake of radiofolates in vitro and in vivo.
Müller C; Brühlmeier M; Schubiger PA; Schibli R
J Nucl Med; 2006 Dec; 47(12):2057-64. PubMed ID: 17138750
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics in mice of four oligomer-conjugated polymers for amplification targeting.
He J; Liu G; Zhang S; Rusckowski M; Hnatowich DJ
Cancer Biother Radiopharm; 2003 Dec; 18(6):941-7. PubMed ID: 14969606
[TBL] [Abstract][Full Text] [Related]
39. (99m)Tc-MORF oligomers specific for bacterial ribosomal RNA as potential specific infection imaging agents.
Chen L; Wang Y; Cheng D; Liu X; Dou S; Liu G; Hnatowich DJ; Rusckowski M
Bioorg Med Chem; 2013 Nov; 21(21):6523-30. PubMed ID: 24054488
[TBL] [Abstract][Full Text] [Related]
40. Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re.
van Schaijk FG; Oosterwijk E; Soede AC; Oyen WJ; McBride WJ; Griffiths GL; Goldenberg DM; Corstens FH; Boerman OC
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3880S-5S. PubMed ID: 14506186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
